financetom
Business
financetom
/
Business
/
Velan 1Q Adjusted Net Loss Narrows on Sales Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Velan 1Q Adjusted Net Loss Narrows on Sales Increase
Jul 12, 2024 4:25 AM

06:53 AM EDT, 07/12/2024 (MT Newswires) -- Velan ( VLNSF ) , a manufacturer of industrial valves, on Thursday said its first-quarter adjusted net loss narrowed on strong sales and an improvement in margin.

The first-quarter adjusted net loss came in at US$1 million, or US$0.05 per share, up from a loss of US$7.9 million, or US$0.37 per share.

Sales during the quarter increased to US$77.5 million from US$67.7 million. Adjusted EBITDA swung to US$3.9 million from a loss of US$3.3 million.

Gross margin also improved to 31% from 22%, the company said.

As at May 31, backlog stood at $528.3 million, up 7.5% from $491.5 million at the beginning of the fiscal year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
APA curtails US natgas and NGL production in second quarter on weak prices
APA curtails US natgas and NGL production in second quarter on weak prices
Jul 9, 2025
July 9 (Reuters) - Oil and gas firm APA Corp ( APA ) said on Wednesday it curtailed about 10 million of cubic feet per day (MMcfpd) of U.S. natural gas production and 750 barrels per day of U.S. natural gas liquids production in the second quarter in response to weak prices. ...
Rhythm Pharmaceuticals to Offer $150 Million in Common Stock
Rhythm Pharmaceuticals to Offer $150 Million in Common Stock
Jul 9, 2025
04:37 PM EDT, 07/09/2025 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) said late Wednesday it plans to offer $150 million of common stock. The company also plans to offer the underwriters a 30-day option to buy up to $22.5 million of additional shares. Shares of the company were down 1.7% in recent after-hours activity. Price: 87.50, Change: -1.50, Percent...
Inventiva Names Jason Campagna Chief Medical Officer
Inventiva Names Jason Campagna Chief Medical Officer
Jul 9, 2025
04:36 PM EDT, 07/09/2025 (MT Newswires) -- Inventiva ( IVA ) said late Wednesday it appointed Jason Campagna as chief medical officer and president of research and development. Campagna succeeds Michael Cooreman, who is departing as chief medical officer. Co-founder and Chief Scientific Officer Pierre Broqua will transition to a consulting role as scientific advisor. Campagna most recently was the...
Uipath Insider Sold Shares Worth $592,668, According to a Recent SEC Filing
Uipath Insider Sold Shares Worth $592,668, According to a Recent SEC Filing
Jul 9, 2025
04:37 PM EDT, 07/09/2025 (MT Newswires) -- Daniel Dines, 10% Owner, Director, CEO and Chairman, on July 09, 2025, sold 45,000 shares in Uipath ( PATH ) for $592,668. Following the Form 4 filing with the SEC, Dines has control over a total of 30,441,961 Class A common shares of the company, with 24,918,585 shares held directly and 5,523,376 controlled...
Copyright 2023-2025 - www.financetom.com All Rights Reserved